Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Praxis Precision Medicines stock in Canada
Own Praxis Precision Medicines shares in just a few minutes.
Praxis Precision Medicines is a biotechnology business based in the US. Praxis Precision Medicines stocks (PRAX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $19.8 – a decrease of 7.01% over the previous week. Praxis Precision Medicines employs 67 staff and has a market cap (total outstanding stock value) of $751.8 million.
How to buy shares in Praxis Precision Medicines
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PRAX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Praxis Precision Medicines stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Praxis Precision Medicines?
- Praxis Precision Medicines shares summary
- Compare share dealing platforms
- Is Praxis Precision Medicines stock a buy or sell?
- Praxis Precision Medicines performance over time
- Praxis Precision Medicines's financials
- Does Praxis Precision Medicines pay a dividend?
- Other common questions
Praxis Precision Medicines stock price (NASDAQ: PRAX)Use our graph to track the performance of PRAX stocks over time.
Praxis Precision Medicines shares at a glance
|Latest market close||$17.11|
|52-week range||$12.71 - $60.95|
|50-day moving average||$20.04|
|200-day moving average||$24.07|
|Wall St. target price||$36.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.47|
Compare online trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Praxis Precision Medicines price performance over time
|1 week (2021-11-24)||-7.01%|
|1 month (2021-11-01)||-21.26%|
|3 months (2021-09-01)||-13.15%|
|6 months (2021-06-01)||-13.32%|
|1 year (2020-12-01)||-59.44%|
|2 years (2019-11-27)||N/A|
|3 years (2018-11-27)||N/A|
|5 years (2016-11-27)||N/A|
Praxis Precision Medicines financials
|Gross profit TTM||$0|
|Return on assets TTM||-37.84%|
|Return on equity TTM||-66.28%|
|Market capitalisation||$751.8 million|
TTM: trailing 12 months
Praxis Precision Medicines share dividends
We're not expecting Praxis Precision Medicines to pay a dividend over the next 12 months.
Praxis Precision Medicines overview
Praxis Precision Medicines, Inc. , a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy. It has a cooperation and license agreement with RogCon Inc. ; a license agreement with Purdue Neuroscience Company; a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc. ; and collaboration with The Florey Institute to develop three novel ASOs.
Stocks similar to Praxis Precision Medicines
Frequently asked questions
Praxis Precision Medicines in the news
Health Care Sector Update for 12/01/2021: ARDX,BHG,BYSI
Why ImmunoGen Stock Is Flying High Today
Why GAN Limited Stock Jumped as Much as 10% in Morning Trading Today
More on investing
We break down how the CRA treats stock gains and losses, how foreign stocks are taxed, which trading expenses are tax-deductible and more.Read more…
Stock trading doesn’t have to be expensive. Using Finder’s proprietary algorithm, we’ve identified the best cheap Canadian and US stocks to buy now.Read more…
We look at 6 popular stock discussion groups from Canada and overseas.Read more…
More guides on Finder
How to buy Intensity Therapeutics (INTS) stock in Canada when it goes public
Everything we know about the Intensity Therapeutics IPO, plus information on how to buy in.
How to buy Incannex Healthcare Limited (IXHL) stock in Canada when it goes public
Everything we know about the Incannex Healthcare Limited IPO, plus information on how to buy in.
How to buy Genenta Science SpA (GNTA) stock in Canada when it goes public
Everything we know about the Genenta Science SpA IPO, plus information on how to buy in.
Top trending stocks on Twitter
We’ve pulled a list together of the top trending stocks being mentioned on Twitter over the past 24 hours.
How to buy Polestar (PSNY) stock in Canada when it goes public
Everything we know about the Polestar IPO, plus information on how to buy in.
How to buy Knightscope (KSCP) stock in Canada when it goes public
Everything we know about the Knightscope IPO, plus information on how to buy in.
How to buy Sangoma Technologies Corporation (STC) stock in Canada
Everything we know about the Sangoma Technologies Corporation IPO, plus information on how to buy in.
How to buy Sweetgreen stock in Canada
Everything we know about the Sweetgreen IPO, plus information on how to buy in.
How to buy UserTesting (USER) stock in Canada
Everything we know about the UserTesting IPO, plus information on how to buy in.
How to buy Sono Motors (SEV) stock in Canada
Everything we know about the Sono Motors IPO, plus information on how to buy in.